| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
GB:ADM
Admiral
|
Aug 11, 2026 | BUY |
Buy
-15.8% avg upside
14 analysts
|
$4400.00
9.44% Upside
|
+6.5% | · |
|
GB:LGEN
Legal & General
|
Aug 11, 2026 | SELL |
Hold
+460.2% avg upside
17 analysts
|
$191.00
34.93% Downside
|
+3.8% | · |
|
GB:CRE
Conduit Holdings Ltd
|
Aug 04, 2026 | BUY |
Buy
+11.2% avg upside
6 analysts
|
$488.00
7.56% Upside
|
+1.7% | · |
|
GB:SBRE
Sabre Insurance Group plc
|
Aug 04, 2026 | HOLD |
Buy
+10.8% avg upside
7 analysts
|
$182.00
6.43% Upside
|
-2.4% | · |
|
GB:LRE
Lancashire Holdings
|
Aug 04, 2026 | BUY |
Buy
+539.7% avg upside
12 analysts
|
$667.00
8.35% Upside
|
+3.6% | · |
|
GB:HSX
Hiscox
|
May 07, 2026 | SELL |
Strong Buy
+275.0% avg upside
15 analysts
|
$1148.00
37.67% Downside
|
-13.0% | · |
|
GB:AV
Aviva plc
|
May 03, 2026 | HOLD |
Buy
-8.4% avg upside
17 analysts
|
$637.00
12.79% Downside
|
+17.9% | · |
|
GB:0HAG
Sampo Plc
|
Feb 11, 2026 | HOLD |
Buy
+95.6% avg upside
15 analysts
|
$10.20
3.50% Upside
|
· | · |
|
GB:BEZ
Beazley
|
Feb 05, 2026 | HOLD |
Strong Buy
+150.2% avg upside
14 analysts
|
$1310.00
0.97% Upside
|
+4.9% | · |
|
GB:0OJC
Gjensidige Forsikring ASA
|
Feb 05, 2026 | BUY |
Sell
-14.0% avg upside
12 analysts
|
$311.00
8.56% Upside
|
· | · |
|
GB:0R78
Tryg A/S
|
Sep 29, 2025 | HOLD |
Buy
+7.5% avg upside
10 analysts
|
$169.00
8.06% Upside
|
· | · |
|
DE:HNR1
Hannover Rueck
|
May 19, 2025 | BUY |
Buy
+3.7% avg upside
16 analysts
|
$309.00
19.97% Upside
|
-6.7% | · |
|
DE:MUV2
Munich Reinsurance
|
Mar 20, 2025 | HOLD |
Buy
-7.5% avg upside
17 analysts
|
$559.00
7.90% Upside
|
-7.1% | · |
|
FR:SCR
SCOR
|
Mar 06, 2025 | BUY |
Buy
-1.3% avg upside
12 analysts
|
$31.00
8.25% Downside
|
+23.7% | · |
|
CH:SREN
Swiss Re AG
|
Mar 03, 2025 | HOLD |
Hold
-13.5% avg upside
15 analysts
|
$156.00
10.45% Upside
|
-6.2% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.